Table 10. Cost-effectiveness of STRs versus gMTRs for the treatment of HIV-1 infection in the United States.

	STR	gMTR	Δ STR-gMTR
Total Costs	$547,540.20	$531,204.29	$16,335.91
Medication Costs	$450,474.20	$423,926.76	$26,547.43
Inpatient Costs	$31,258.18	$43,293.79	-$12,035.61
Other Costs	$65,807.83	$63,983.73	$1,824.09
Life Years	15.400	14.785	0.614
QALY	14.466	13.847	0.619
		ICER ($/QALY)	$26,383.82

gMTR, generic multiple-tablet regimen; ICER, Incremental cost-effectiveness ratio; QALY, Quality adjusted life years; STR, Single-tablet regimen.